Literature DB >> 24919401

Binding of human apoA-I[K107del] variant to TG-rich particles: implications for mechanisms underlying hypertriglyceridemia.

Irina N Gorshkova1, Xiaohu Mei2, David Atkinson2.   

Abstract

We found earlier that apoA-I variants that induced hypertriglyceridemia (HTG) in mice had increased affinity to TG-rich lipoproteins and thereby impaired their catabolism. Here, we tested whether a naturally occurring human apoA-I mutation, Lys107del, associated with HTG also promotes apoA-I binding to TG-rich particles. We expressed apoA-I[Lys107del] variant in Escherichia coli, studied its binding to TG-rich emulsion particles, and performed a physicochemical characterization of the protein. Compared with WT apoA-I, apoA-I[Lys107del] showed enhanced binding to TG-rich particles, lower stability, and greater exposure of hydrophobic surfaces. The crystal structure of truncated, Δ(185-243), apoA-I suggests that deletion of Lys107 disrupts helix registration and disturbs a stabilizing salt bridge network in the N-terminal helical bundle. To elucidate the structural changes responsible for the altered function of apoA-I[Lys107del], we studied another mutant, apoA-I [Lys107Ala]. Our findings suggest that the registry shift and ensuing disruption of the inter-helical salt bridges in apoA-I[Lys107del] result in destabilization of the helical bundle structure and greater exposure of hydrophobic surfaces. We conclude that the structural changes in the apoA-I[Lys107del] variant facilitate its binding to TG-rich lipoproteins and thus, may reduce their lipolysis and contribute to the development of HTG in carriers of the mutation.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  apolipoprotein A-I; high plasma triglyceride levels; natural mutation; triglyceride; very low density lipoprotein

Mesh:

Substances:

Year:  2014        PMID: 24919401      PMCID: PMC4617355          DOI: 10.1194/jlr.M047241

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  52 in total

Review 1.  HDL metabolism in hypertriglyceridemic states: an overview.

Authors:  B Lamarche; S Rashid; G F Lewis
Journal:  Clin Chim Acta       Date:  1999-08       Impact factor: 3.786

2.  Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.

Authors:  A von Eckardstein; H Funke; M Walter; K Altland; A Benninghoven; G Assmann
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

3.  Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion.

Authors:  Y H Chen; J T Yang; H M Martinez
Journal:  Biochemistry       Date:  1972-10-24       Impact factor: 3.162

4.  Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.

Authors:  Mary G Sorci-Thomas; Shaila Bhat; Michael J Thomas
Journal:  Clin Lipidol       Date:  2009-02

5.  Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe.

Authors:  G V Semisotnov; N A Rodionova; O I Razgulyaev; V N Uversky; A F Gripas'; R I Gilmanshin
Journal:  Biopolymers       Date:  1991-01       Impact factor: 2.505

Review 6.  Pathophysiology of hypertriglyceridemia.

Authors:  H C Hassing; R P Surendran; H L Mooij; E S Stroes; M Nieuwdorp; G M Dallinga-Thie
Journal:  Biochim Biophys Acta       Date:  2011-12-10

7.  Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.

Authors:  Angeliki Chroni; Horng-Yuan Kan; Adelina Shkodrani; Tong Liu; Vassilis I Zannis
Journal:  Biochemistry       Date:  2005-03-15       Impact factor: 3.162

8.  The conformation of lipid-free human apolipoprotein A-I in solution.

Authors:  Ricquita D Pollard; Brian Fulp; Michael P Samuel; Mary G Sorci-Thomas; Michael J Thomas
Journal:  Biochemistry       Date:  2013-12-17       Impact factor: 3.162

Review 9.  Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity.

Authors:  Shirya Rashid; Takehiko Watanabe; Taro Sakaue; Gary F Lewis
Journal:  Clin Biochem       Date:  2003-09       Impact factor: 3.281

10.  Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity.

Authors:  Nahuel A Ramella; Guillermo R Schinella; Sergio T Ferreira; Eduardo D Prieto; María E Vela; José Luis Ríos; M Alejandra Tricerri; Omar J Rimoldi
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more
  4 in total

Review 1.  Lipid-free Apolipoprotein A-I Structure: Insights into HDL Formation and Atherosclerosis Development.

Authors:  Xiaohu Mei; David Atkinson
Journal:  Arch Med Res       Date:  2015-06-03       Impact factor: 2.235

2.  Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity.

Authors:  Irina N Gorshkova; Xiaohu Mei; David Atkinson
Journal:  J Lipid Res       Date:  2017-12-05       Impact factor: 5.922

3.  Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia.

Authors:  Irina N Gorshkova; David Atkinson
Journal:  JSM Atheroscler       Date:  2017-02-13

4.  Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?

Authors:  Madhurima Das; Christopher J Wilson; Xiaohu Mei; Thomas E Wales; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2015-11-10       Impact factor: 5.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.